0001341004-14-000522.txt : 20140624 0001341004-14-000522.hdr.sgml : 20140624 20140611141039 ACCESSION NUMBER: 0001341004-14-000522 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140611 FILED AS OF DATE: 20140611 DATE AS OF CHANGE: 20140611 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NEOVASC INC CENTRAL INDEX KEY: 0001399708 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36458 FILM NUMBER: 14904206 BUSINESS ADDRESS: STREET 1: 2135 13700 Mayfield place CITY: RICHMOND STATE: A1 ZIP: 00000 BUSINESS PHONE: 604-270-4344 MAIL ADDRESS: STREET 1: 2135 13700 Mayfield place CITY: RICHMOND STATE: A1 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: Medical Ventures Corp DATE OF NAME CHANGE: 20070516 6-K 1 form6k.htm 6-K form6k.htm
 
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934


 
For the month of
  
June
  
 
2014
 
Commission File Number
  
001-36458
    
 
Neovasc Inc.
(Translation of registrant’s name into English)
 
Suite 2135 — 13700 Mayfield Place
 Richmond, British Columbia, Canada, V6V 2E4
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F
  
Form 40-F
X

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):          

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):           




 
 
 
 

 
DOCUMENTS INCLUDED AS PART OF THIS REPORT


Document
    
     
1
  
Form 51-102F3 - Material Change Report.


 
 
 

DOCUMENT 1
 
 
 

 
 
 

FORM 51-102F3
 
MATERIAL CHANGE REPORT
 
Item 1.
  
Name and Address of Company
     
   
Neovasc Inc. (the “Company”)
   
13700 Mayfield Place, Suite 2135
   
Richmond, BC,
   
V6V 2E4
     
Item 2.
  
Date of Material Change
     
   
June 6, 2014
     
Item 3.
  
News Release
     
   
A news release announcing this material change was issued June 6, 2014 and a copy has been filed on SEDAR.
     
Item 4.
  
Summary of Material Changes
     
   
On June 6, 2014, the Company announced that it had been made aware of a lawsuit filed by CardiAQ Valve Technologies.
     
Item 5.
  
5.1 – Full Description of Material Change
     
   
On June 6, 2014, the Company announced that it had been made aware of a lawsuit filed by CardiAQ Valve Technologies in the U.S. District Court for the District of Massachusetts, including certain allegations relating to Neovasc’s transcatheter mitral valve technology, including the Tiara™ device.
     
   
As of the date of this report, the complaint has not yet been served on the Company.  If CardiAQ does serve the complaint, Neovasc intends to vigorously defend itself. Based on its understanding of the unproven allegations, the Company believes the lawsuit to be groundless and without merit.
     
   
5.2 – Disclosure for Restructuring Transactions
     
   
Not applicable.
     
Item 6.
  
Reliance on subsection 7.1(2) of National Instrument 51-102
     
   
Not applicable.
     
Item 7.
  
Omitted Information
     
   
Not applicable.
     
Item 8.
  
Executive Officer
     
   
For further information, please contact Chris Clark, Chief Financial Officer of the Company, at 604-270-4344.
     
Item 9.
  
Date of Report
     
   
June 11, 2014.

 
 

 
 
 


SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 
Neovasc Inc.
 
(Registrant)
 
Date:
  
 
June 11, 2014
  
 
By:
  
 
/s/ Chris Clark
   
Name:   Chris Clark
Title:     Chief Financial Officer